Blood Banking and Transfusion Flashcards
6 cards from real ABPATH practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.
Read the first 6 Blood Banking and Transfusion flashcards as text
A 68-year-old male with a history of myelodysplastic syndrome receives a transfusion of 2 units of packed red blood cells. Five days later, he presents with a low-grade fever, mild jaundice, and a greater than expected drop in his hemoglobin level. A direct antiglobulin test (DAT) is now positive. Which of the following is the most likely cause of this presentation?
Answer: Delayed hemolytic transfusion reaction
The patient's presentation of symptoms such as fever and jaundice several days after a transfusion, along with a positive DAT and unexpected anemia, is characteristic of a delayed hemolytic transfusion reaction (DHTR). [8, 15] This reaction occurs when a patient has been previously sensitized to a red blood cell antigen and has an anamnestic antibody response upon re-exposure through transfusion. [26] Acute reactions occur within 24 hours, TA-GVHD has different primary symptoms, and febrile reactions typically do not involve hemolysis or a positive DAT.
A blood bank technologist is resolving an ABO discrepancy. The forward typing shows A positive, while the reverse typing is consistent with group O (anti-A and anti-B are reactive). The patient is a 75-year-old male with multiple myeloma. What is the most likely cause of this discrepancy?
Answer: Rouleaux formation
The discrepancy described (forward type A, reverse type O) is a classic example of a Group III ABO discrepancy. [2] In patients with conditions causing hyperproteinemia, such as multiple myeloma, red blood cells can non-specifically aggregate in a 'stack of coins' appearance known as rouleaux formation. [14] This can cause false agglutination in the forward typing. Saline replacement or dilution techniques can typically resolve this type of discrepancy. [14]
Which of the following is the primary reason for irradiating cellular blood components?
Answer: To prevent transfusion-associated graft-versus-host disease (TA-GVHD)
The sole purpose of irradiating cellular blood products is to inactivate donor T-lymphocytes, thereby preventing their proliferation and engraftment in a susceptible recipient. [19, 36, 38] This action prevents transfusion-associated graft-versus-host disease (TA-GVHD), a rare but highly fatal complication of transfusion. [36, 39] Irradiation does not eliminate bacteria or viruses.
A patient with disseminated intravascular coagulation (DIC) and significant hypofibrinogenemia requires factor replacement. Which blood component is the most concentrated source of fibrinogen?
Answer: Cryoprecipitate
Cryoprecipitate is a plasma-derived product that is prepared by thawing Fresh Frozen Plasma and collecting the cold-insoluble precipitate. [5, 13] This process concentrates several clotting factors, most notably fibrinogen, as well as Factor VIII, Factor XIII, and von Willebrand factor. [10, 37] It is the most concentrated source of fibrinogen available for transfusion. [10]
A patient develops acute respiratory distress, hypoxemia, and bilateral pulmonary infiltrates on chest X-ray within 2 hours of receiving a platelet transfusion. There are no signs of circulatory overload. Which of the following is the most likely diagnosis?
Answer: Transfusion-Related Acute Lung Injury (TRALI)
The clinical presentation of acute respiratory distress, non-cardiogenic pulmonary edema, and hypoxemia occurring within 6 hours of a transfusion is the classic definition of Transfusion-Related Acute Lung Injury (TRALI). [4, 18, 35] It is a leading cause of transfusion-related mortality. [4] The absence of signs of heart failure or volume overload helps distinguish it from TACO. [28]
Which of the following infectious agents is NOT universally tested for on all allogeneic blood donations in the United States?
Answer: Cytomegalovirus (CMV)
While all blood donations in the U.S. are tested for a panel of infectious agents including HIV, HCV, HBV, and others, Cytomegalovirus (CMV) testing is not performed on every unit. [9, 12, 23] CMV testing is typically performed on a subset of donations to provide CMV-seronegative products for specific at-risk patient populations, such as premature infants and transplant recipients.
Written and edited by Nathan Beja, founder of Practice Test Geeks, with AI assistance. Exam facts are checked against the official sources linked below. Editorial policy
Sources & references
Exam facts on this page (fees, format, dates, passing scores) are checked against these official sources; the date is our last check. Editorial policy
- abpath.org — Exam format, time limit, exam dates, fees, registration, retake policy, score release, test dates, passing score, exam information · verified Nov 2026
- home.pearsonvue.com — Test delivery · verified Nov 2026